Affymetrix, Leica Roll out Automated RNA In Situ Hybridization Assay Platform | GenomeWeb

This article has been corrected from a previous version. Micah Litow's name and title have been corrected, and Affymetrix's relationship with Leica has been clarified.

NEW YORK (GenomeWeb) — Affymetrix recently announced the availability of its ViewRNA eZ assays on Leica Biosystems's fully automated Bond RX staining platform, a combined offering that the companies believe will appeal to pharmaceutical companies, translational researchers, and molecular diagnostics firms.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.